GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

The purpose of black box warnings is to draw immediate attention to the most serious potential adverse effects of a drug, ...

He is studying methazolamide, a treatment currently used to manage glaucoma, to find out if it can also help treat ...

Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...